Elucidata
India · $16.0M raised
- Business Model
- B2B SaaS
- Website
- elucidata.io
- Total Funding
- $16.0M
- Last Round
- $16.0M Series ASep 2022
- Rounds
- 1
About
TechBio company powering life science R&D with ML-Ops platform Polly for drug discovery and biomedical data integration.
Summary
Elucidata is an Artificial Intelligence company based in India. It has raised $16.0M in total across 1 round, most recently a $16.0M Series A round in Sep 2022. Investors include Eight Roads Ventures, F-Prime Capital and IvyCap Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2022
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
Neuralink is building a brain-computer interface for medical needs and greater human potential.